Showing 7441-7450 of 20885 results for "".
- Research Breakthrough on Birth Defect Affecting Brain Sizehttps://reachmd.com/news/research-breakthrough-on-birth-defect-affecting-brain-size/2462932/Nonsense-mediated RNA decay, or NMD, is an evolutionarily conserved molecular mechanism in which potentially defective messenger RNAs, or mRNAs (genetic material that instructs the body on how to make proteins), are degraded. Disruption of the NMD pathway can lead to neurological disord
- Researchers Reveal a New Approach for Treating Degenerative Diseaseshttps://reachmd.com/news/researchers-reveal-a-new-approach-for-treating-degenerative-diseases/2462910/Proteins are the workhorses of life. Organisms use them as building blocks, receptors, processors, couriers and catalysts. A protein’s structure is critical to its function. Malformed proteins not only fail to carry out their tasks, they can accumulate and eventually gum up the inner workings of
- Unique Dietary Assessment Tool Launched for Clinicians by ACLMhttps://reachmd.com/news/unique-dietary-assessment-tool-launched-for-clinicians-by-aclm/2462915/The American College of Lifestyle Medicine (ACLM) has developed a clinical tool to help health care professionals incorporate a food as medicine approach into their practice by assessing and tracking the proportion of whole
- Cleveland Clinic Study Finds Common Artificial Sweetener Linked to Higher Rates of Heart Attack and Strokehttps://reachmd.com/news/cleveland-clinic-study-finds-common-artificial-sweetener-linked-to-higher-rates-of-heart-attack-and-stroke/2462922/New Cleveland Clinic research showed that erythritol, a popular artificial sweetener, is associated with an increased risk of heart attack and stroke. Findings were published today in
- Lilly Resubmits BLA for Lebrikizumabhttps://reachmd.com/news/lilly-resubmits-bla-lebrikizumab/2462907/Eli Lilly and Company announced as part of its 2024 first-quarter financial report that it as resubmitted the biologic license application (BLA) for lebrikizumab to the U.S. Food and Drug Administration for the treatment of people 12 and older with moderate-to-severe atopic dermatitis (eczema), t
- The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics, and Equityhttps://reachmd.com/news/the-aspirin-conundrum-navigating-negative-results-age-aging-dynamics-and-equity/2462897/Credit: Pixabay/CC0 Public Domain A new study examining the role of aspirin in breast cancer treatment reveals critical issu
- Pandemic Fatigue and Vaccine Hesitancy Continue to Affect Global Public Health, New 23-Country Study in Nature Medicine Reportshttps://reachmd.com/news/pandemic-fatigue-and-vaccine-hesitancy-continue-to-affect-global-public-health-new-23-country-study-in-nature-medicine-reports/2462901/Responses from 23,000 people point to need for more locally relevant communication strategies to increase vaccine confidenceNEW YORK, April 29, 2024 /PRNewswire/ -- While it found that global uptake of at least one COVID
- Uptick in NYC Transit Assault Rate During COVID Pandemic; Has Not Returned to Pre-Pandemic Levels Despite Subway Safety Planhttps://reachmd.com/news/uptick-in-nyc-transit-assault-rate-during-covid-pandemic-has-not-returned-to-pre-pandemic-levels-despite-subway-safety-plan/2462904/April 29, 2024-- Has the New York City subway become less safe? This is the question Columbia University Mailman School of Public Health researchers sought to answer in their newest paper investigating rates of complaints to and arrests by the N
- Op-Ed: Men Aren’t Typically Part of Fertility Conversations—Until Something Goes Wronghttps://reachmd.com/news/op-ed-men-arent-typically-part-of-fertility-conversationsuntil-something-goes-wrong/2462891/Once you decide that parenthood is in your near future, the path initially seems straightforward: start monitoring your diet, make an appointment with y
- Study Suggests Staying Current with COVID-19 Vaccinations Helps Combat Emerging Variantshttps://reachmd.com/news/study-suggests-staying-current-with-covid-19-vaccinations-helps-combat-emerging-variants/2462899/A COVID-19 vaccine is prepped at an OHSU clinic. New research from OHSU reveals a strong immune response to an updated vaccine in the fall of 2023, suggesting a clear benefit for people receiving updated vaccinations regularly, especially older adults and those with underlyi